在阿尔茨海默病中解读神经炎症:精准医学的多omics和AI驱动的视角
Shiyu Lin1, Yijun Zhan1, Ruiqi Wang1
1Department of Acupuncture, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Frontiers in immunology
|July 3, 2025
概括
单细胞RNA测序 (scRNA-seq) 揭示了阿尔茨海默病 (AD) 脑组织中的新型细胞子集和分子标记物. 这种方法有助于理解免疫-炎症网络,以改善AD诊断和个性化治疗.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特征是粉样β沉积,高酸化和神经炎症.
- 目前阿尔茨海默病的治疗选择有限,尽管最近的研究进展.
研究的目的:
- 利用单细胞RNA测序 (scRNA-seq) 来进行AD脑组织中细胞异质性的高分辨率分析.
- 在阿尔茨海默病中识别新型疾病相关的细胞子集和分子标记物.
主要方法:
- 利用单细胞RNA测序 (scRNA-seq) 克服了传统批量组织分析的局限性.
- 集成scRNA-seq数据与人工智能驱动的分析和多omics平台.
主要成果:
- 发现了新的与疾病相关的细胞子集,包括亲炎性微质细胞和反应性星体细胞.
- 确定了对阿尔茨海默病进展至关重要的关键分子标记物.
结论:
- scRNA-seq增强了对阿尔茨海默病复杂免疫-炎症网络的理解.
- 这一策略支持准确的分类,早期诊断AD亚型和个性化治疗开发.
相关概念视频
01:26Alzheimer's Disease: Overview
675
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
675
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265